Director's Share Dealings February 21, 2014 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces it was notified on February 20, 2014 that on that day, Matthew Emmens, the Company's Chairman, sold 36,100 Ordinary Shares in the Company ("Shares") at an average sale price of £33.14853. The Shares were sold on the London Stock Exchange. Following the above transaction, Mr Emmens holds 56,774 Shares and 5,872 American Depositary Shares in the Company ("ADSs"). Each ADS represents three Shares. This notification is to satisfy the Company's obligations under 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules. Tony Guthrie Deputy Company Secretary For further information please contact: Investor Relations Laurie Stelzer email@example.com +1 858 754 5480 Eric Rojas firstname.lastname@example.org +1 781 482 0999 Sarah Elton-Farr email@example.com +44 1256 894157 Notes to editors Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas. www.shire.com Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX Press Release www.shire.com END -0- Feb/21/2014 12:00 GMT
SHIRE PLC: Director’s Share Dealings
Press spacebar to pause and continue. Press esc to stop.